BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23064936)

  • 1. ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions.
    Tinmouth J; Ritvo P; McGregor SE; Guglietti C; Green J; Claus D; Levitt C; Paszat LF; Rabeneck L
    Can Fam Physician; 2012 Oct; 58(10):e570-7. PubMed ID: 23064936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ColonCancerCheck primary care invitation pilot project: patient perceptions.
    Tinmouth J; Ritvo P; McGregor SE; Patel J; Guglietti C; Levitt CA; Paszat LF; Rabeneck L
    Can Fam Physician; 2013 Dec; 59(12):e541-9. PubMed ID: 24336559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative evaluation of strategies to increase colorectal cancer screening uptake.
    Tinmouth J; Ritvo P; McGregor SE; Claus D; Pasut G; Myers RE; Guglietti C; Paszat LF; Hilsden RJ; Rabeneck L
    Can Fam Physician; 2011 Jan; 57(1):e7-15. PubMed ID: 21322288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
    Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
    BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family physicians' choices of and opinions on colorectal cancer screening modalities.
    Zettler M; Mollon B; da Silva V; Howe B; Speechley M; Vinden C
    Can Fam Physician; 2010 Sep; 56(9):e338-44. PubMed ID: 20841573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
    Buchman S; Rozmovits L; Glazier RH
    Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are physicians' recommendations for colorectal cancer screening guideline-consistent?
    Yabroff KR; Klabunde CN; Yuan G; McNeel TS; Brown ML; Casciotti D; Buckman DW; Taplin S
    J Gen Intern Med; 2011 Feb; 26(2):177-84. PubMed ID: 20949328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive result on a fecal occult blood test in Ontario's ColonCancerCheck program.
    Stock D; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
    Curr Oncol; 2017 Feb; 24(1):47-51. PubMed ID: 28270725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians.
    Charters TJ; Strumpf EC; Sewitch MJ
    BMC Health Serv Res; 2013 Oct; 13():449. PubMed ID: 24168208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.
    Şahin MK; Aker S
    J Cancer Educ; 2017 Dec; 32(4):908-913. PubMed ID: 27193411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' use of nonphysician healthcare providers for colorectal cancer screening.
    Sansbury LB; Klabunde CN; Mysliwiec P; Brown ML
    Am J Prev Med; 2003 Oct; 25(3):179-86. PubMed ID: 14507523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.
    Shin HY; Suh M; Park B; Jun JK; Choi KS
    BMC Cancer; 2017 Dec; 17(1):860. PubMed ID: 29246126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.